本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

CRISPR Therapeutics AG

41.86
+3.298.53%
盤後41.900.0684+0.16%19:59 EDT
成交量:472.63萬
成交額:1.96億
市值:36.15億
市盈率:-9.27
高:42.36
開:39.59
低:39.59
收:38.57
資料載入中...
2022/02/15

重要事件披露

8-K - Current report
2022/02/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/20

重要事件披露

8-K - Current report
2021/12/07

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/18

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/14

重要事件披露

8-K - Current report
2021/10/12

重要事件披露

8-K - Current report
2021/09/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/07/29

重要事件披露

8-K - Current report
2021/07/29

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]